Insurers hope for drug price transparency legislation — at a minimum
An insurance lobbyist hopes at least to win legislation next year requiring drug companies to disclose more information about their pricing as a means to control pharmaceutical costs. Price controls, said Paul Sanford of the Florida Insurance Council, would be a much bigger lift, and would have to happen on the national level. But requiring price transparency as a condition of doing business in Florida might be realistic within a year or two, he said. “If you really want to…
You might be interested in
